Saram ConsultingGxP & AI Consulting for Life Sciences. Custom AI integrations, Part 11 compliance validation, and equity-based engineering partnerships for biotech.Explore Services at saram.io →
Back to Home

Enovis

NYSE: ENOV $18.04 USD~$1.1B MCAP

Enovis Corporation is a medical technology company focused on clinically differentiated orthopedic and musculoskeletal solutions, operating through Prevention and Recovery (orthopedic bracing, pain management, physical therapy products) and Reconstructive (joint replacement implants, instruments, and enabling technologies) segments. Formerly known as Colfax Corporation, the company distributed its products through independent distributors and direct sales forces until September 1, 2026, when it announced a binding offer to acquire eCential Robotics, a French surgical-robotics developer, for an initial enterprise value of €155 million.

Company Info

Sector:Medical Technology / Orthopedics
Headquarters:Wilmington, Delaware, USA
Founded:1995

Recent News

No recent news updates available for this company.

Leadership Team

Matt Trerotola

Chief Executive Officer

Careers & Job Openings

See all open roles

Multiple Departments
Wilmington, DE / Global
Apply Now